Topiramate for the treatment of post traumatic stress disorder. A case study;Topiramaat bij de posttraumatische stressstoornis

Tijdschrift voor Psychiatrie

Volumn 48, Issue 6, 2006, Pages 487-491

  Aalbersberg, C F ^a,b   Mulder, J M V ^a  

^a GGZ Noord Holland Noord ^*  (Netherlands)

^b GGZ Den Helder   (Netherlands)

Author keywords

Post traumatic; Stress disorders; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PSYCHOTRAUMA; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; HUMANS; MALE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 33745527178     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. American Psychiatric Association. (2004). Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Press.
2. Arnone, D. (2005). Review of the use of Topiramate for treatment of psychiatric disorders. Annals of General Psychiatry, 4, 5.
3. Berg, M.P. van den, & Jongedijk, R.A. (2004). Farmacotherapie van de posttraumatische stressstoornis. Tijdschrift voor Psychiatrie, 46, 357-368.
4. Berlant, J.L. (2003). Antiepileptic treatment of posttraumatic stress disorder. Primary Psychiatry, 10, 41-49.
5. Berlant, J.L. (2004). Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry, 4, 24.
6. Berlant, J.L., & van Kammen D.P. [2002). Open-label topiramate as primary or adjunctive therapy in chronic civilian posrtraumatic stress disorder: a preliminary report. The Journal of Clinical Psychiatry, 63, 15-20.
7. Brady, K., Pearlstein, T., Asnis G.M., e.a. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. The Journal of the American Medical Association, 283, 1837-1844.
8. Davidson, J., Kudler, H., Smith, R., e.a. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259-266.
9. Davidson, J.R., Rothbaum, B.O., van der Kolk, B.A., e.a. (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry, 58, 485-492.
10. Hertzberg, M.A., Butterfield, M.I., Feldman, M.E., e.a. (1999). A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biological Psychiatry, 45, 1226-1229.
11. Kessler, R.C., Sonnega, A., Bromet, E., e.a. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1058-1060.
12. Kosten, T.R., Frank, J.B., Dan, E., e.a. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. The Journal of Nervous and Mental Disease, 179, 366-370.
13. Kwaliteitsinstituut voor de gezondheidszorg. (2003). Multidisciplinaire Richtlijn Angststoornissen. Utrecht: Kwaliteitsinstituut voor de gezondheidszorg CBO.
14. Marshall, R.D., Beebe, K.L., Oldham, M., e.a. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. The American Journal of Psychiatry, 158, 1982-1988.
15. Martenyi, F., Brown, E.B., Zhang, H., e.a. (2002). Fluoxetine versus placebo in posttraumatic stress disorder. The Journal of Clinical Psychiatry, 63, 199-206.
16. Silberstein, S.D. (2002). Control of topiramate-induced paresthesias with supplemental potassium. Headache, 42, 85.
17. Tucker, P., Zaninelli, R., Yehuda, R., e.a. (2001). Paroxerine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. The Journal of Clinical Psychiatry, 62, 860-868.
18. White, H.S. (2005). Molecular pharmacology of topiramate: managing seizures and preventing migraine. Headache, 45(Suppl. 1), S48-S56.
19. Zullino, D.F., Krenz, S., & Besson, J. (2003). AMPA blockade may be the mechanism underlying the efficacy of topiramate in PTSD. The Journal of Clinical Psychiatry, 64, 219-220.